Everest Pharmakon Private Limited

Everest Pharmakon Private Limited - pharma in New Delhi, Delhi, India. FY 2026 financials & compliance.
CIN U24230DL2009PTC195326 Incorporated 19 October 2009 ROC Delhi HQ New Delhi, Delhi, India
Active Private Limited Company pharma
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
17 yrs
Est. 2009
Directors on board
4
As per MCA filings
Active GSTINs
1
of 2 registered
Last financials
Mar 2024
Balance sheet date
Last AGM
30 Sep 2024
Annual general meeting
Company status
Active
MCA master data

About Everest Pharmakon Private Limited

Data last updated:

Everest Pharmakon Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 19 October 2009 and has been in existence for over 17 years.

The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24230DL2009PTC195326. Its GSTIN is 07AACCE2515P2ZI (Delhi). The company holds 2 GST registrations, of which 1 is active.

The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Hem Lata Chaubey and Jai Prakash Chaubey.

Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 24 Metro Apparment Dda(Sfs) Flats Poket – 8 Sector – 13 Dwa, Rka, New Delhi, Delhi, India – 110075.

The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U24230DL2009PTC195326
Registration Number 195326
Incorporation Date 19 October 2009
ROC Delhi
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant

Contact details

Everest Pharmakon Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    24 Metro Apparment Dda(Sfs) Flats Poket – 8 Sector – 13 Dwa, Rka, New Delhi, Delhi, India – 110075
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors

To see the full contact details of Everest Pharmakon Private Limited, buy the company report.

Comprehensive company report
Everest Pharmakon Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Financials of Everest Pharmakon Private Limited

FY 2024 filings available

Financial Statement Summary

MetricsFY 2022-23FY 2021-22FY 2020-21FY 2019-20FY 2018-19
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA
Profit Before Tax
Tax Expense
Net Profit (PAT)
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2022-23FY 2021-22FY 2020-21FY 2019-20FY 2018-19
Profitability
EBITDA Margin
Net Profit Margin
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Everest Pharmakon Private Limited, buy the company report.

Board of directors of Everest Pharmakon Private Limited

Everest Pharmakon has 4 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Hem Lata ChaubeyDirector19 Oct 200917 Years 0 MonthsCurrent
Jai Prakash ChaubeyDirector12 Nov 200917 Years 0 MonthsCurrent
Uma ChaubeyDirector07 May 20242 Years 6 MonthsCurrent
Babita ChaubeyDirector07 May 20242 Years 6 MonthsCurrent

Auditor

Everest Pharmakon Private Limited is audited by ASHISH MISHRA & CO. for the financial year 2023.

Auditor firmFinancial yearFirm registration number
ASHISH MISHRA & CO.FY 2023023434N

Shareholding

The shareholding of Everest Pharmakon Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Everest Pharmakon Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Everest Pharmakon Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Everest Pharmakon has 2 GST registrations: 1 active and 1 cancelled or inactive.

Total GSTINs
2
Active
1
Cancelled / inactive
1
GSTINStateStatusRegistered on
07AACCE2515P2ZIDelhiActive28 Jun 2024

To see the full GST registrations and return filing status of Everest Pharmakon Private Limited, buy the company report.

Recent activity

Everest Pharmakon Private Limited has 6 board changes on record since 2009: 5 appointments and 1 cessation. The latest: Babita Chaubey was appointed as Director on 07 May 2024.

AGM
Everest Pharmakon Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Appointed
Babita Chaubey was appointed as Director.
Appointed
Uma Chaubey was appointed as Director.
Filing
Everest Pharmakon Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi.
Ceased
Ramesh Khatiwada Kumar ceased to be Director.
Appointed
Jai Prakash Chaubey was appointed as Director.
Appointed
Hem Lata Chaubey was appointed as Director.
Appointed
Ramesh Khatiwada Kumar was appointed as Director.
Incorporation
19 Oct 2009
Everest Pharmakon Private Limited was registered on 19 Oct 2009 with Roc Delhi & aged 17 years 29 days as per MCA records.

Frequently asked questions

Everest Pharmakon is an active private limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 19 October 2009 (17+ years old) and is registered under CIN U24230DL2009PTC195326.

Everest Pharmakon has 4 current directors:

The latest financial statements of Everest Pharmakon on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.

The GSTIN of Everest Pharmakon is 07AACCE2515P2ZI, registered in Delhi. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.

The CIN (Corporate Identification Number) of Everest Pharmakon is U24230DL2009PTC195326. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Everest Pharmakon was incorporated on 19 October 2009, making it 17+ years old. It is registered with the Registrar of Companies, Delhi.

Babita Chaubey was appointed as Director on 07 May 2024. Uma Chaubey was appointed as Director on 07 May 2024. Ramesh Khatiwada Kumar ceased to be Director on 31 Mar 2014. Everest Pharmakon has 6 board changes on record in total.

The registered office of Everest Pharmakon is at 24 Metro Apparment DdaSfs Flats Poket – 8 Sector – 13 Dwa, Rka, New Delhi, Delhi, India – 110075.

Everest Pharmakon operates in the pharma industry, in the pharmaceutical retailers and distributors segment.

The compliance status of Everest Pharmakon is compliant as of 04 August 2026. The company is actively filing with the Registrar of Companies.